| CXHB2000019 | 泽布替尼胶囊 | zanubrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-03-24 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-03-23 | view |
| CXHB2000023 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs | Supplementary Application | 2020-04-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-04-03 | view |
| CXHB2000046 | BGB-290 胶囊 | pamiparib | Capsule | Chemical Drugs | Supplementary Application | 2020-05-28 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-05-27 | view |
| CXHB2000072 | 泽布替尼胶囊 | zanubrutinib | Capsule | Chemical Drugs(原1.1) | Supplementary Application | 2020-08-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-08-19 | view |
| CXHB2000095 | 帕米帕利胶囊 | pamiparib | Capsule | Chemical Drugs(1) | Supplementary Application | 2020-09-23 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-09-22 | view |
| CXHB2100005 | 泽布替尼胶囊 | zanubrutinib | Capsule | Chemical Drugs(1) | Supplementary Application | 2021-01-09 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2021-01-08 | view |
| CXHB2100057 | 泽布替尼胶囊 | zanubrutinib | Capsule | Chemical Drugs(原1.1) | Supplementary Application | 2021-04-10 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2022-01-27 | view |
| CXHL1301259 | BGB-283胶囊 | lifirafenib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1301260 | BGB-283胶囊 | lifirafenib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1301261 | BGB-283胶囊 | lifirafenib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1301262 | BGB-283 | lifirafenib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1401941 | BGB-3111 | zanubrutinib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2015-02-13 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-03-11 | view |
| CXHL1401942 | BGB-3111胶囊 | zanubrutinib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-02-13 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-03-11 | view |
| CXHL1401948 | BGB-3111胶囊 | zanubrutinib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-02-13 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-03-11 | view |
| CXHL1501848 | BGB-290 | pamiparib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1501849 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1501850 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1501851 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1501852 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1700333 | BGB-3245-MBP | BGB-3245-MBP | Injection | Chemical Drugs(1) | New Drug Application | 2018-08-17 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2018-08-15 | view |
